pentobarbital decreases levels of panobinostat by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Solid CYP3A4 inducers can lessen panobinostat amounts by ~70% and bring about treatment failure. Can only be offered in premises which happen to be registered pharmacies and b